CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study is trying to identify the right dose of a long-acting medicine called WIN378 for people with moderate or severe asthma. WIN378 bl...
Phase 2
Pittsburgh, Pennsylvania, United States and 72 other locations
immunogenicity of APG777 in adult participants with mild-to-moderate asthma.The duration of the study will be approximately 52 weeks (364 da...
Phase 1
Pittsburgh, Pennsylvania, United States and 12 other locations
The primary objective of this study is to describe the efficacy of rocatinlimab in reducing asthma exacerbations....
Phase 2
Pittsburgh, Pennsylvania, United States and 154 other locations
This study is trying to find the right dose of a long-lasting medicine called GSK5784283 for people with asthma that remains uncontrolled ev...
Phase 2
Pittsburgh, Pennsylvania, United States and 138 other locations
trifenatate (FF/UMEC/VI) with inhaled corticosteroids/long-acting beta-2 agonists (ICS/LABA) in adult participants with uncontrolled asthma...
Phase 4
Pittsburgh, Pennsylvania, United States and 116 other locations
The purpose of this study is to assess the PD equivalence of the approved asthma combination therapy, BDA, delivered using the proposed repl....
Phase 3
Scottdale, Pennsylvania, United States and 127 other locations
This study is researching a drug called dupilumab. The study is focused on patients who have uncontrolled asthma. Asthma is a condi...
Phase 4
Pittsburgh, Pennsylvania, United States and 84 other locations
This Phase 2b study is designed to evaluate the safety and efficacy of KT-621 in participants with uncontrolled moderate to severe eosinophilic asthma...
Phase 2
Pittsburgh, Pennsylvania, United States and 8 other locations
This is a phase 2, open-label extension study to evaluate the long-term safety and efficacy of lunsekimig in adult participants with asthma ...
Phase 2
Pittsburgh, Pennsylvania, United States and 116 other locations
levels compared with placebo in participants with moderate-to-severe asthma.Study participation will last approximately 65 weeks, including ...
Phase 2
Pittsburgh, Pennsylvania, United States and 120 other locations
Clinical trials
Research sites
Resources
Legal